Novel 2-(5-Aryl-4,5-Dihydropyrazol-1-yl)thiazol-4-One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights

Novel 2-(5-Aryl-4,5-Dihydropyrazol-1-yl)thiazol-4-One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights

Tarfah Al-Warhi,1 Ahmed M El Kerdawy,2,3 Mohamed A Said,4 Amgad Albohy,5 Zainab M Elsayed,6 Nada Aljaeed,1 Eslam B Elkaeed,7 Wagdy M Eldehna,8,9 Hatem A Abdel-Aziz,10 Miral A Abdelmoaz11 1Department of Chemistry, College of Science, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia;...

Full description

Bibliographic Details
Main Authors: Al-Warhi T, El Kerdawy AM, Said MA, Albohy A, Elsayed ZM, Aljaeed N, Elkaeed EB, Eldehna WM, Abdel-Aziz HA, Abdelmoaz MA
Format: Article
Language:English
Published: Dove Medical Press 2022-05-01
Series:Drug Design, Development and Therapy
Subjects:
antitumor
egfr inhibitors
pyrazolo
molecular docking
lung cancer
Online Access:https://www.dovepress.com/novel-2-5-aryl-45-dihydropyrazol-1-ylthiazol-4-one-as-egfr-inhibitors--peer-reviewed-fulltext-article-DDDT

Internet

https://www.dovepress.com/novel-2-5-aryl-45-dihydropyrazol-1-ylthiazol-4-one-as-egfr-inhibitors--peer-reviewed-fulltext-article-DDDT

Similar Items